BeOne Medicines Ltd. (ONC) is listed on NASDAQ in Pharmaceutical Stocks. It is $366.76, -1.54%, with a $542.1B market cap. RSI is 62.3, near overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 62.3 Near Overbought
Market Cap $542.1B
Volume 149.7K
Fundamentals — 10-Q Q2 2026
Revenue $3.2B
Net Income $464.4M
EPS $0.31
Gross Margin 89.4%
Operating Margin 17.9%
Net Margin 14.4%
Debt / Equity 0.2x
P/E Ratio 1183.1x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Wu Xiaobin | President and COO | Sell | 280 | $380.00 | $106,400 | 2026 Aug 25 |
| Oyler John | Chief Executive Officer | Sell | 240,810 | $359.12 | $86.5M | 2026 Aug 12 |
| Lee Chan Henry | SVP, General Counsel | Sell | 2,666 | $360.00 | $959,760 | 2026 Aug 11 |
| Rosenberg Aaron | Chief Financial Officer | Sell | 1,157 | $312.71 | $361,811 | 2026 Aug 3 |
| Lee Chan Henry | SVP, General Counsel | Sell | 1,044 | $323.69 | $337,932 | 2026 Jul 30 |
| Lee Chan Henry | SVP, General Counsel | Sell | 1,669 | $325.00 | $542,425 | 2026 Jul 22 |
| Oyler John | Chief Executive Officer | Sell | 109,713 | $315.28 | $34.6M | 2026 Jul 21 |
| Oyler John | Chief Executive Officer | Sell | 64,628 | $312.00 | $20.2M | 2026 Jul 17 |
| Oyler John | Chief Executive Officer | Sell | 283,154 | $315.56 | $89.4M | 2026 Jul 16 |
| Oyler John | Chief Executive Officer | Sell | 145,861 | $305.95 | $44.6M | 2026 Jul 14 |
| Oyler John | Chief Executive Officer | Sell | 60,218 | $303.18 | $18.3M | 2026 Jul 13 |
| Lee Chan Henry | SVP, General Counsel | Sell | 664 | $302.46 | $200,833 | 2026 Jul 8 |
| Wu Xiaobin | President and COO | Sell | 1,292 | $276.26 | $356,927 | 2026 Jun 23 |
| Oyler John | Chief Executive Officer | Sell | 3,410 | $273.78 | $933,592 | 2026 Jun 23 |
| Wang Lai | President, Global Head of R&D | Sell | 1,068 | $276.74 | $295,553 | 2026 Jun 23 |
| Wu Xiaobin | President and COO | Sell | 1,357 | $266.76 | $361,997 | 2026 Jun 16 |
| Oyler John | Chief Executive Officer | Sell | 3,693 | $265.55 | $980,686 | 2026 Jun 16 |
| Lee Chan Henry | SVP, General Counsel | Sell | 590 | $265.98 | $156,925 | 2026 Jun 16 |
| Wang Lai | President, Global Head of R&D | Sell | 1,169 | $265.39 | $310,236 | 2026 Jun 16 |
| Ball Titus B. | Principal Accounting Officer | Sell | 169 | $257.20 | $43,467 | 2026 Jun 11 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $64.65 | 51.0 | $12.5B |
| | $72.17 | 37.1 | $10.0B |
| | $345.04 | 48.5 | $9.6B |
| | $76.62 | 35.2 | $15.0B |
Take ONC further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put ONC in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when BeOne Medicines Ltd. next reports.
Set alerts on ONC
Get notified when BeOne Medicines Ltd. hits your price targets or technical conditions are met.
Get Started Free